Damsky, William http://orcid.org/0000-0003-0975-4071
Wang, Alice
Kim, Daniel J.
Young, Bryan D.
Singh, Katelyn
Murphy, Michael J.
Daccache, Joseph http://orcid.org/0000-0003-4847-4398
Clark, Abigale
Ayasun, Ruveyda http://orcid.org/0000-0001-8699-084X
Ryu, Changwan
McGeary, Meaghan K. http://orcid.org/0000-0002-8505-7158
Odell, Ian D.
Fazzone-Chettiar, Ramesh
Pucar, Darko
Homer, Robert http://orcid.org/0000-0002-2055-5885
Gulati, Mridu
Miller, Edward J.
Bosenberg, Marcus http://orcid.org/0000-0003-0166-1612
Flavell, Richard A. http://orcid.org/0000-0003-4461-0778
King, Brett http://orcid.org/0000-0002-4576-4616
Funding for this research was provided by:
Pfizer (n/a - investigator initiated research)
Ranjini and Ajay Poddar Fund for Dermatologic Diseases Research; philanthropic gift to Yale University.
Article History
Received: 19 April 2021
Accepted: 5 May 2022
First Online: 6 June 2022
Competing interests
: W.D. has research funding from Pfizer and Advanced Cell Diagnostics/Bio-techne, serves as a consultant for Eli Lilly, Pfizer, Incyte, and Twi Biotechnology, and receives licensing fees from EMD/Millipore/Sigma. B.D.Y receives research funding from Pfizer. E.J.M. receives research funding from Alnylam, Pfizer, and Eidos and serves as a consultant for Alnylam, Pfizer, and Eidos. D.P. receives consulting fees from Telix Pharmaceuticals and Cohere Health. M.B. is a consultant for Eli Lilly and receives licensing fees from EMD/Millipore//Sigma. R.A.F. is a consultant for Glaxo Smith Kline and Zai labs. B.K. is a consultant to and/or has served on advisory boards for Aclaris Therapeutics, Arena Pharmaceuticals, Bristol-Meyers Squibb, Concert Pharmaceuticals Inc, Dermavant Sciences, Eli Lilly and Company, Pfizer, and VielaBio; he is on speaker’s bureau for Pfizer, Regeneron and Sanofi Genzyme. A.W., D.J.K., K.S., M.J.M., J.D., A.C., R.A., C.R., M.K.M., I.D.O., R.F.C., R.H. and M.G. have no disclosures.